NewsBot Registered Joined 6 Aug 2002 Messages 2 Reaction score 0 23 Jun 2026 #1 Bevacizumab Secures Approval in Japan as World's First Therapy for Neurofibromatosis Type 2 NeurologyLive Continue reading...
Bevacizumab Secures Approval in Japan as World's First Therapy for Neurofibromatosis Type 2 NeurologyLive Continue reading...